Literature DB >> 27870565

Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer.

Kenneth E Rosenzweig1, Jorge E Gomez1.   

Abstract

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A 72-year-old man with a 40-pack-year tobacco history developed a cough and decreased exercise tolerance. A chest x-ray demonstrated a right-upper-lobe opacity. Chest computed tomography (CT) scan revealed a 2.5-cm mass in the right upper lobe with multiple mediastinal lymph node disease ( Fig 1 ). A positron emission tomography (PET) scan confirmed the lung lesion and the mediastinal lymphadenopathy without distant metastases. Brain magnetic resonance imaging results were negative. The biopsy specimen revealed adenocarcinoma with no actionable mutations present. Cervical mediastinoscopy was positive for carcinoma in level 2, 3, 4R, and 7 lymph nodes; level 4L was negative. The patient's stage was T1bN2M0, stage IIIA. His medical history was significant for hyperlipidemia and hypothyroidism. He had smoked one pack a day for 40 years and had quit 15 years earlier. Physical examination was unrevealing, and the patient had an Eastern Cooperative Oncology Group performance status of 0. Because of the extent of lung cancer in the mediastinum, the patient's cancer was deemed inoperable, and he was referred for consideration of concurrent chemotherapy and radiation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27870565     DOI: 10.1200/JCO.2016.69.9678

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  17 in total

Review 1.  Regulatory mechanisms and potential medical applications of HNF1A-AS1 in cancers.

Authors:  Yang Zhang; Jiang Shi; Junfang Luo; Cong Liu; Lixu Zhu
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Concurrent inhibition of ErbB family and MEK/ERK kinases to suppress non-small cell lung cancer proliferation.

Authors:  Xiaofeng Lin; Jipei Liao; Xinyan Geng; Hancai Dan; Long Chen
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

3.  Caffeic Acid Phenethyl Ester-Incorporated Radio-Sensitive Nanoparticles of Phenylboronic Acid Pinacol Ester-Conjugated Hyaluronic Acid for Application in Radioprotection.

Authors:  Seon-Hee Choi; Dong-Yeon Lee; Sohi Kang; Min-Kyung Lee; Jae-Heun Lee; Sang-Heon Lee; Hye-Lim Lee; Hyo-Young Lee; Young-Il Jeong
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

4.  Synthetic Secoisolariciresinol Diglucoside (LGM2605) Protects Human Lung in an Ex Vivo Model of Proton Radiation Damage.

Authors:  Anastasia Velalopoulou; Shampa Chatterjee; Ralph A Pietrofesa; Cynthia Koziol-White; Reynold A Panettieri; Liyong Lin; Stephen Tuttle; Abigail Berman; Constantinos Koumenis; Melpo Christofidou-Solomidou
Journal:  Int J Mol Sci       Date:  2017-11-25       Impact factor: 5.923

5.  Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer.

Authors:  Banglun Qian; Xiang Wang; Chao Mao; Yiqun Jiang; Ying Shi; Ling Chen; Shuang Liu; Bin Wang; Shu Pan; Yongguang Tao; Hongcan Shi
Journal:  Thorac Cancer       Date:  2018-03-13       Impact factor: 3.500

Review 6.  Tissue-specific and exosomal miRNAs in lung cancer radiotherapy: from regulatory mechanisms to clinical implications.

Authors:  Long Long; Xue Zhang; Jian Bai; Yizhou Li; Xiaolong Wang; Yunfeng Zhou
Journal:  Cancer Manag Res       Date:  2019-05-13       Impact factor: 3.989

7.  Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells.

Authors:  Li Zhou; Ming Li; Xinyou Yu; Feng Gao; Wei Li
Journal:  Int J Biol Sci       Date:  2019-03-01       Impact factor: 6.580

8.  miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer.

Authors:  Yue Yuan; Hu Liao; Qiang Pu; Xixian Ke; Xueting Hu; Yongfang Ma; Xinmei Luo; Qianqian Jiang; Yi Gong; Min Wu; Lunxu Liu; Wen Zhu
Journal:  Signal Transduct Target Ther       Date:  2020-06-12

9.  CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer.

Authors:  Changpeng Hu; Qian Zhang; Qin Tang; Huyue Zhou; Wuyi Liu; Jingbin Huang; Yali Liu; Qin Wang; Jing Zhang; Min Zhou; Fangfang Sheng; Wenjing Lai; Jing Tian; Guobing Li; Rong Zhang
Journal:  J Cell Mol Med       Date:  2019-11-13       Impact factor: 5.310

Review 10.  The Impact of Javanica Oil Emulsion Injection on Chemotherapy Efficacy and Cellular Immune Indicators in Patients with Advanced NSCLC: A Systematic Review and Meta-Analysis.

Authors:  Huilin Xu; Zhucheng Yin; Anbing He; Dedong Cao
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.